These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38. Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model. de Wit E; Feldmann F; Cronin J; Goldin K; Mercado-Hernandez R; Williamson BN; Meade-White K; Okumura A; Callison J; Weatherman S; Rosenke R; Avanzato VA; Lovaglio J; Scott DP; Marzi A; Feldmann H EBioMedicine; 2023 Jan; 87():104405. PubMed ID: 36508878 [TBL] [Abstract][Full Text] [Related]
39. Nipah Virus Efficiently Replicates in Human Smooth Muscle Cells without Cytopathic Effect. DeBuysscher BL; Scott DP; Rosenke R; Wahl V; Feldmann H; Prescott J Cells; 2021 May; 10(6):. PubMed ID: 34070626 [TBL] [Abstract][Full Text] [Related]
40. Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. Wang YE; Park A; Lake M; Pentecost M; Torres B; Yun TE; Wolf MC; Holbrook MR; Freiberg AN; Lee B PLoS Pathog; 2010 Nov; 6(11):e1001186. PubMed ID: 21085610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]